BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 11377677)

  • 41. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
    Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
    J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tissue mast cells in health and disease.
    Parwaresch MR; Horny HP; Lennert K
    Pathol Res Pract; 1985 Mar; 179(4-5):439-61. PubMed ID: 2582403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-1992. A 57-year-old man with a 20-year history of episodic headache, Flushing, hypotension, and occasional syncope.
    N Engl J Med; 1992 Feb; 326(7):472-81. PubMed ID: 1732774
    [No Abstract]   [Full Text] [Related]  

  • 44. Mastocytosis - an update.
    Amon U; Hartmann K; Horny HP; Nowak A
    J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
    Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
    Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Acute myelomonocytic leukemia with mastocytosis in bone marrow].
    Natori H; Nakamura E; Tanaka K; Naito K; Egami K; Honda J; Osabe S; Imamura Y; Natori K; Yasuda K
    Rinsho Ketsueki; 1990 Feb; 31(2):239-44. PubMed ID: 2329687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
    Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
    Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current state of biology and diagnosis of clonal mast cell diseases in adults.
    Alvarez-Twose I; Morgado JM; Sánchez-Muñoz L; García-Montero A; Mollejo M; Orfao A; Escribano L
    Int J Lab Hematol; 2012 Oct; 34(5):445-60. PubMed ID: 22551157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma.
    Chott A; Guenther P; Huebner A; Selzer E; Parwaresch RM; Horny HP; Valent P
    Am J Surg Pathol; 2003 Jul; 27(7):1013-9. PubMed ID: 12826896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells.
    Valent P; Samorapoompichit P; Sperr WR; Horny HP; Lechner K
    Hematol J; 2002; 3(2):90-4. PubMed ID: 12032870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
    Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
    Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis.
    Reichard KK; Chen D; Pardanani A; McClure RF; Howard MT; Kurtin PJ; Wood AJ; Ketterling RP; King RL; He R; Morice WG; Hanson CA
    Am J Clin Pathol; 2015 Sep; 144(3):493-502. PubMed ID: 26276780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic mast cell disease without associated hematologic disorder: a combined retrospective and prospective study.
    Pardanani A; Baek JY; Li CY; Butterfield JH; Tefferi A
    Mayo Clin Proc; 2002 Nov; 77(11):1169-75. PubMed ID: 12440552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow.
    Natkunam Y; Rouse RV
    Am J Surg Pathol; 2000 Jan; 24(1):81-91. PubMed ID: 10632491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry.
    Baumgartner C; Sonneck K; Krauth MT; Kneidinger M; Födinger M; Hauswirth AW; Müllauer L; Valent P
    Eur J Clin Invest; 2008 May; 38(5):326-35. PubMed ID: 18363719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis.
    Aberer E; Sperr WR; Bretterklieber A; Avian A; Hadzijusufovic E; Kluin-Nelemans HC; Oude Elberink H; van Anrooij B; Niedoszytko M; Lange M; Górska A; Elena C; Brazzelli V; Belloni Fortina A; Caroppo F; Hartmann K; Illerhaus A; Reiter A; Jawhar M; Bonadonna P; Zanotti R; Triggiani M; Parente R; Gotlib J; Doubek M; von Bubnoff N; Fuchs D; Sabato V; Brockow K; Jäkel N; Panse J; Valent P
    J Invest Dermatol; 2021 Jul; 141(7):1719-1727. PubMed ID: 33581142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
    Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
    Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The international consensus classification of mastocytosis and related entities.
    Leguit RJ; Wang SA; George TI; Tzankov A; Orazi A
    Virchows Arch; 2023 Jan; 482(1):99-112. PubMed ID: 36214901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation.
    Spyridonidis A; Thomas AK; Bertz H; Zeiser R; Schmitt-Gräff A; Lindemann A; Waller CF; Finke J
    Bone Marrow Transplant; 2004 Sep; 34(6):515-9. PubMed ID: 15273711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
    Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
    J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.